
China launches world’s first brain-computer interface for quadriplegic patients
China launches world’s first brain-computer interface for quadriplegic patients
- China's drug regulator has granted approval for a groundbreaking brain-computer interface system aimed at helping individuals with paralysis.
- The invasive device, developed by Borui Kang Medical Technology, restores hand movement capabilities specifically for patients with quadriplegia.
- The approval signifies a crucial advance in medical technology in China, expected to impact public use within three to five years.
Story
China has recently achieved a significant milestone by becoming the first country to approve a brain-computer interface (BCI) device, a pioneering move in the realm of medical technology. This device, developed by Borui Kang Medical Technology based in Shanghai, represents a breakthrough for individuals suffering from paralysis, particularly patients with quadriplegia due to cervical spinal cord injuries. The BCI system assists these patients in regaining hand movement capabilities through the use of a specialized glove, which is controlled by implanting electrodes directly into the brain, leveraging minimally invasive extradural implantation techniques and wireless technology. The implications of this approval are profound, as the National Medical Products Administration categorizes such innovative medical technologies as a “future industry” in China's latest five-year plan. This designation highlights the Chinese government's commitment to supporting advancements in medical technology, positioning the country to emerge as a leader in this innovative sector. The fast-paced development comes as China makes strides to compete with U.S. companies in the same field, particularly startups like Neuralink, founded by Elon Musk, which is working on similar technologies. Clinical trials conducted with participants include stringent guidelines, wherein patients must have a diagnosis at least one year old and maintain a stable condition for a minimum of six months after standard treatments. Notably, they should possess some degree of upper-arm function but be unable to grasp with their hands. The clinical trial data indicated a significant improvement in hand-grasping abilities among the trial participants, which substantially enhanced their quality of life. In the coming three to five years, China anticipates that this brain-computer interface technology could become practically usable for the public, enabling further advancements in rehabilitation, mobility, and personal independence for those affected by severe motor impairments. As the technology matures and implementations proliferate, there is a potential to see a profound impact on healthcare and the lives of countless individuals affected by paralysis.